`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`
`
`PHARMACOSMOS A/S
`Petitioner
`
`v.
`
`LUITPOLD PHARMACEUTICALS, INC.
`Patent Owner
`_______________
`
`
`
`
`
`
`
` Cases1 IPR2015-01490; Patent 7,754,702 B2
`
`
`IPR2015-01493; Patent 8,431,549 B2
`
`
`IPR2015-01495; Patent 8,895,612 B2
`
`____________________________________________________________
`
`Petitioner’s Objection to Patent Owner Response in Lieu of Motion
`(to Patent Owner Response in Lieu of Motion, Paper 9)
`
`
`
`
`
`
`
`
`
`1 As required by Paper 8, Petitioner attests that the word-for-word identical paper is
`being filed in each proceeding identified in the heading.
`
`
`
`IPR2015-01490; IPR2015-01493; IPR2015-01495
`
`
`
`The Board gave Patent Owner permission to submit a motion requesting
`
`authorization to file a certificate of correction to change “103” to “103” in claim 26
`
`of US Patent No. 7,754,702, and in claim 12 of US Patent No. 8,895,612 by
`
`October 20, 2015. However, the Patent Owner instead filed a “Response in Lieu of
`
`Motion” (“Response”), electing not to file a motion requesting a certificate of
`
`correction.
`
`Since Patent Owner chose not to file a motion, Patent Owners’ paper
`
`couched as a “Response,” but containing argument, is inappropriate and should not
`
`have been filed. At this particular stage in the proceedings, such arguments are not
`
`permitted. As such, Petitioner respectfully requests that the Board disregard the
`
`arguments made therein. In the event that the Board chooses to consider the
`
`arguments presented in the “Response,” Petitioner disagrees with Patent Owner’s
`
`statement that “Petitioner is thus not prejudiced by the Board agreeing that ‘n’ is
`
`correctly about ‘103’”. Response at 1.
`
`
`
`Moreover, and for clarity’s sake, Petitioner states that in response to Patent
`
`Owners’ inquiry received after the Board granted permission to file a motion,
`
`Petitioner indicated an inability to consent at the present time to a motion to correct
`
`(1) certain claims; and (2) a portion of the specification. This second issue was not
`
`identified to the Board as a basis for the contemplated motion. Petitioner did,
`
`Active 21313898.1
`
`1
`
`
`
`
`
`IPR2015-01490; IPR2015-01493; IPR2015-01495
`
`however, express a willingness to consider a motion explaining the basis for the
`
`proposed amendments.
`
`
`
`Respectfully submitted,
`
`BAKER BOTTS L.L.P.
`
`
`/s/ Lisa Kole
`
`
`
`ATTORNEYS FOR PETITIONER,
`PHARMACOSMOS A/S
`
`Lisa Kole (PTO Reg. No. 35,225)
`Steven Lendaris (PTO Reg. No. 53,202)
`Paul Ragusa (PTO Reg. No. 38,587)
`
`Baker Botts L.L.P.
`30 Rockefeller Plaza
`New York, NY 10112
`Telephone: (212) 408-2500
`Facsimile: (212) 408-2501
`Email: lisa.kole@bakerbotts.com
`steven.lendaris@bakerbotts.com
`paul.ragusa@bakerbotts.com
`
`
`
`
`
`
`
`
`
`October 30, 2015
`Date
`
`
`
`
`
`
`
`
`
`
`Active 21313898.1
`
`2
`
`
`
`
`
`IPR2015-01490; IPR2015-01493; IPR2015-01495
`
`CERTIFICATE OF SERVICE
`
`
`
`The undersigned certifies that a copy of the foregoing paper is being served
`
`on October 30, 2015, by filing through the Patent Review Processing System and
`
`delivering a copy via email to the counsel for Patent Owner at the addresses of
`
`record:
`
`Respectfully submitted,
`
`
`
`
`
`/s/ Lisa Kole
`
`Lisa Kole (PTO Reg. No. 35,225)
`Baker Botts L.L.P.
`30 Rockefeller Plaza
`New York, NY 10112
`Telephone: (212) 408-2500
`Facsimile: (212) 408-2501
`Email: lisa.kole@bakerbotts.com
`
`
`
`
`
`George E. Quillin
`Michael D. Kaminski
`Foley & Lardner L.L.P
`3000 K Street, N.W., Suite 600
`Washington, D.C. 20007
`gquillin@foley.com
`mkaminski@foley.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: October 30, 2015